BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

12 articles for J Gundu

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
AEBI
Advinus Therapeutics
Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine AEBI
Advinus Therapeutics
Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.EBI
Advinus Therapeutics
Discovery of a potent and selective small molecule hGPR91 antagonist.EBI
Advinus Therapeutics
Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.EBI
TBA
Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.EBI
Advinus Therapeutics
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-EBI
Lupin
Discovery of a Potent and Selective PI3Kδ Inhibitor (EBI
Lupin
Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterization.EBI
Lupin
Discovery of Potent, Selective, and State-Dependent NaEBI
Lupin
Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization.EBI
Lupin
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate.EBI
Lupin